Analysis and pharmacokinetics for drug development

Our services

Bioanalysis

Pharmacokinetics

Pharmaceutical Analysis

DNA/RNA Analysis

We are your partner for many kind of studies

Metabolism studies

Preclinical studies:

  • Dose-finding studies
  • Toxicological studies
  • Pharmacokinetic studies
  • Toxicokinetic studies
  • ADME or ADME-Tox studies
  • DMPK studies

Clinical trials (phases 0-III)

Bioequivalence/bioavailability studies

Biomarker development and validation

Biomarker studies

Stability studies

Enzyme activity studies

Biosimilar studies

Pharmacokinetic issues

You have questions or need more information
Please contact us!

This is what our customers say

``Prolytic is our analytical partner throughout the entire drug development process. Such a long and complex process requires a laboratory you can trust. Professional yet flexible, Prolytic accompanies us through the preclinical and clinical phases.``- Omeicos Therapeutics GmbH
„Whether GLP-, GCP-analysis, method development work (non-GLP) or complex analytical questions, with Prolytic we have found a competent and trustworthy partner, with whom we are always happy to work with again.”- MetrioPharm Deutschland GmbH